Replicon particle vaccine protects swine against influenza

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 33, Issue 6, 2010, Pages

  Bosworth, B ^a   Erdman, M M ^a   Stine, D L ^b   Harris, I ^a   Irwin, C ^a   Jens, M ^c   Loynachan, A ^a,f   Kamrud, K ^d   Harris, D L ^a,e  

^a IOWA STATE UNIVERSITY   (United States)

^b Newport Laboratories   (United States)

^c AMVC Management Services   (United States)

^d AlphaVax Inc   (United States)

^e Harrisvaccines Inc   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Hemagglutinin (HA); Maternal antibody; Pigs; Replicon particle (RP) vaccine; Swine; Swine influenza virus (SIV)

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MATERNAL ANTIBODY; NUCLEOPROTEIN; PLACEBO; REPLICON PARTICLE VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ALPHA VIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; NONHUMAN; SWINE; SWINE INFLUENZA; VIRUS IMMUNITY;

ALPHAVIRUS; ANIMALS; ANTIBODIES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNITY, MATERNALLY-ACQUIRED; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; REPLICON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SWINE; SWINE DISEASES; VACCINES, VIRUS-LIKE PARTICLE; VIRAL CORE PROTEINS;

ALPHAVIRUS; ORTHOMYXOVIRIDAE; SUIDAE; SWINE INFLUENZA VIRUS;

EID: 78650185857     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2010.05.002     Document Type: Article

References (19)

1. Gaydos J.C., Top F.H., Hodder R.A., Russell P.K. Swine influenza a outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 2006, 12(1):23-28.
2. Robinson J.L., Lee B.E., Patel J., Bastien N., Grimsrud K., Seal R.F., et al. Swine influenza (H3N2) infection in a child and possible community transmission. Can Emerg Infect Dis 2007, 13(12):1865-1870.
3. Gray G.C., McCarthy T., Capuano A.W., Setterquist S.F., Olsen C.W., Alavanja M.C., et al. Swine workers and swine influenza virus infections. Emerg Infect Dis 2007, 13(12):1871-1878.
4. Olsen C.W. The emergence of novel swine influenza viruses in North America. Virus Res 2002, 85(2):199-210.
5. Ma W., Lager K.M., Vincent A.L., Janke B.H., Gramer M.R., Richt J.A. The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 2008, 56(6-7):326-337.
6. Vincent A.L., Lager K.M., Janke B.H., Gramer M.R., Richt J.A. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vet Microbiol 2008, 126:310-323.
7. Lee J., Gramer M., Joo H. Comparative efficacy of commercial swine influenza virus vaccines against an H3N2 virus variant. Proceedings of the 19th IPVS 2006, 267.
8. Bikour M.H., Cornaglia E., Elazhary Y. Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs. Can J Vet Res 1996, 60:312-314.
9. Gramer M. Swine influenza virus: epidemiology, diagnostics, and research updates. Proceedings of the 40th annual meeting of AASV 2009, 471-473.
10. Van Reeth K., Labarque G., De Clercq S., Pensaert M. Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection. Vaccine 2001, 19:4479-4486.
11. De Filette M., Jou W.M., Birkett A., Lyons K., Schultz B., Tonkyro A., et al. Universal influenza A vaccine: optimization of M2-based constructs. Virology 2005, 337:149-161.
12. Erdman M.M., Kamrud K.I., Harris D.L., Smith J. Alphavirus vector vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept. Vaccine 2010, 28:594-596.
13. Kamrud K.I., Custer M., Dudek J.M., Owens G., Alterson K.D., Lee J.S., et al. Alphavirus replicon approach to promoterless analysis of IRES elements. Virology 2007, 360:376-387.
14. Halbur P.G., Paul P.S., Frey M.L., Landgraf J., Eernisse K., Meng X.J., et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 1995, 32:648-660.
15. Palmer D.F., Coleman M.T., Dowdle W.R., Schild G.C. Advanced laboratory techniques for influenza diagnosis 1975, Public Health Service, US Department of Health, Education, and Welfare, Part 2-hemagglutination inhibition test, pp. 25-62.
16. Richt J.A., Lager K.M., Clouser D.F., Spackman E., Suarez D.L., Yoon K.-J. Real-time reverse transcription-polymerase chain reaction assays for the detection and differentiation of North American swine influenza viruses. J Vet Diagn Invest 2004, 16:367-373.
17. Reed L.J., Muench H. A simple method of estimating fifty percent endpoint. Am J Hyg 1938, 27:493-497.
18. Vander Veen R., Kamrud K., Mogler M., Loyanchan A.L., McVicker J., Berglund P., et al. Rapid development of an efficacious swine vaccine for novel H1N1. PLoS Curr Influenza 2009, RRN1123.
19. Wesley R.D., Lager K.M. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotien of swine influenza virus. Vet Microbiol 2006, 118:67-75.